policy
Aminoglycoside use in cattle and small ruminants
The AVMA does not support extralabel use of aminoglycosides in cattle or small ruminants due to the substantial risk for violative residues in food…
policy
Annual rabies vaccination waiver
Waivers of rabies vaccination should only be issued with approval from the appropriate public health authorities upon recommendation from a licensed…
policy
Extralabel use of medicated feeds, including veterinary feed directive drugs, for minor species
The AVMA supports regulatory discretion in enforcing extralabel use of medicated feeds in minor species under veterinary oversight.
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Joint AVMA-FVE-CVMA statement on the benefits of animal vaccination programs in advancing animal and human health
This statement has been adopted jointly by the AVMA, Federation of Veterinarians of Europe and Canadian Veterinary Medical Association.
policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
policy
Representation to the United States Pharmacopeial Convention (USP)
The AVMA encourages expansion of veterinary membership to the USP, such as representation of veterinary pharmacologists.